New targets for obesity pharmacotherapy (Q36793609)

16 August 2017

1 reference

title

New targets for obesity pharmacotherapy (English)

1 reference

16 August 2017

0 references

0 references

Aronne LJ

1

1 reference

PubMed ID

17438540

16 August 2017

Thornton-Jones ZD

series ordinal

2

1 reference

PubMed ID

17438540

16 August 2017

language of work or name

English

0 references

publication date

1 May 2007

1 reference

Clinical Pharmacology & Therapeutics

16 August 2017

1 reference

16 August 2017

81

1 reference

16 August 2017

5

1 reference

16 August 2017

748-752

1 reference

NPY receptors as drug targets for the central regulation of body weight

16 August 2017

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100163

Endocannabinoids in appetite control and the treatment of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100163

The emerging science of body weight regulation and its impact on obesity treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100163

7 January 2021

Central nervous system control of food intake and body weight

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100163

7 January 2021

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100163

1 reference

7 January 2021

Subtypes Y1 and Y2 of the neuropeptide Y receptor are respectively expressed in pro-opiomelanocortin- and neuropeptide-Y-containing neurons of the rat hypothalamic arcuate nucleus.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100163

7 January 2021

Anatomy and regulation of the central melanocortin system

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100163

7 January 2021

Insulin and its evolving partnership with leptin in the hypothalamic control of energy homeostasis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100163

7 January 2021

Gastrointestinal satiety signals I. An overview of gastrointestinal signals that influence food intake

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100163

7 January 2021

Pancreatic signals controlling food intake; insulin, glucagon and amylin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100163

7 January 2021

Leptin-regulated endocannabinoids are involved in maintaining food intake

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100163

7 January 2021

Evidence for an interaction between CB1 cannabinoid and melanocortin MCR-4 receptors in regulating food intake.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100163

7 January 2021

Selective inhibition of sucrose and ethanol intake by SR 141716, an antagonist of central cannabinoid (CB1) receptors.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100163

7 January 2021

The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100163

7 January 2021

Activation of the peripheral endocannabinoid system in human obesity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100163

7 January 2021

Dysregulation of the peripheral and adipose tissue endocannabinoid system in human abdominal obesity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100163

7 January 2021

Central serotonin and melanocortin pathways regulating energy homeostasis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100163

7 January 2021

Serotonin Reciprocally Regulates Melanocortin Neurons to Modulate Food Intake

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100163

7 January 2021

Low-dose leptin reverses skeletal muscle, autonomic, and neuroendocrine adaptations to maintenance of reduced weight

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100163

7 January 2021

Neuropeptide Y5 receptor antagonism does not induce clinically meaningful weight loss in overweight and obese adults

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100163

7 January 2021

Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100163

7 January 2021

The cannabinoid CB1 receptor antagonist SR141716A reduces appetitive and consummatory responses for food.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100163

7 January 2021

Effect of limiting snack food variety on long-term sensory-specific satiety and monotony during obesity treatment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100163

7 January 2021

Identification of targets of leptin action in rat hypothalamus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100163

7 January 2021

Synergy of sibutramine and low-dose leptin in treatment of diet-induced obesity in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100163

7 January 2021

beta(3)-Adrenoceptor agonists: potential, pitfalls and progress

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100163

7 January 2021

Effects of bupropion on core body temperature of mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100163

7 January 2021

Identifiers

DOI

10.1038/SJ.CLPT.6100163

1 reference

16 August 2017

1 reference

PubMed ID

17438540